NeuroOne Medical Technologies will announce its Q3 2025 financial results and host an investor call on August 14, 2025.
Quiver AI Summary
NeuroOne Medical Technologies Corporation has announced that it will release its financial results for the fiscal third quarter ending June 30, 2025, on August 14, 2025, before the market opens. The company's management will hold an investor conference call at 8:30 a.m. Eastern time on the same day to discuss the results, provide corporate updates, and engage in a Q&A session. Participants are encouraged to join the call five minutes early, and a recording of the call will be available until August 28, 2025. NeuroOne focuses on developing minimally invasive solutions for neurological disorders like epilepsy and Parkinson’s disease, with potential expansions into other medical areas. For further information, interested parties can visit the company's website.
Potential Positives
- NeuroOne is scheduled to release its financial results for the third quarter of fiscal year 2025, indicating transparency and accountability to investors.
- The company is hosting an investor conference call to provide a corporate update and engage with stakeholders, showcasing a commitment to communication.
- NeuroOne is focused on developing minimally invasive and high-definition solutions for treating a range of neurological disorders, positioning itself in a growing healthcare market with significant unmet needs.
Potential Negatives
- Failure to disclose any financial results or performance metrics, potentially indicating underlying issues or lack of transparency.
- Only providing a vague description of corporate updates may suggest a lack of significant progress or developments since the last update.
- Setting the conference call for a later date without any immediate details may lead to speculation regarding the state of the company's financial health.
FAQ
When will NeuroOne release its third quarter financial results?
NeuroOne will release its fiscal third quarter financial results on August 14, 2025, before market open.
What time is the investor conference call for the third quarter results?
The investor conference call will take place at 8:30 a.m. Eastern time on August 14, 2025.
How can I join the NeuroOne earnings conference call?
To participate, dial 888-506-0062 (U.S. Toll Free) or 973-528-0011 (International), using access code 939482.
Will there be a replay of the earnings call available?
Yes, a playback of the call will be available through August 28, 2025, at 877-481-4010 in the U.S.
What is NeuroOne's focus as a medical technology company?
NeuroOne focuses on developing minimally invasive solutions for EEG recording, brain stimulation, and treating neurological disorders.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$NMTC Insider Trading Activity
$NMTC insiders have traded $NMTC stock on the open market 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $NMTC stock by insiders over the last 6 months:
- RONALD W. MCCLURG (Chief Financial Officer) purchased 200,000 shares for an estimated $100,000
- DAVID A ROSA (CEO and President) purchased 100,000 shares for an estimated $50,000
- MARK CHRISTIANSON (Business Development Director) has made 0 purchases and 3 sales selling 21,019 shares for an estimated $13,109.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NMTC Hedge Fund Activity
We have seen 9 institutional investors add shares of $NMTC stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 191,162 shares (+20.8%) to their portfolio in Q1 2025, for an estimated $162,525
- GOLDMAN SACHS GROUP INC added 98,573 shares (+inf%) to their portfolio in Q1 2025, for an estimated $83,806
- CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. added 81,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $68,866
- CITADEL ADVISORS LLC removed 71,695 shares (-87.6%) from their portfolio in Q1 2025, for an estimated $60,955
- JANE STREET GROUP, LLC removed 39,951 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $33,966
- J.W. COLE ADVISORS, INC. added 37,120 shares (+inf%) to their portfolio in Q1 2025, for an estimated $31,559
- GEODE CAPITAL MANAGEMENT, LLC added 34,317 shares (+11.0%) to their portfolio in Q1 2025, for an estimated $29,176
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NMTC Analyst Ratings
Wall Street analysts have issued reports on $NMTC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Ladenburg Thalmann issued a "Buy" rating on 05/05/2025
To track analyst ratings and price targets for $NMTC, check out Quiver Quantitative's $NMTC forecast page.
Full Release
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal third quarter ended June 30, 2025, before market open on August 14, 2025.
Management will host an investor conference call and webcast at 8:30 a.m. Eastern time on Thursday, May 14, 2025, to discuss the Company’s third quarter fiscal year 2025 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:
Third Quarter 2025 Earnings Conference Call
Date: Thursday, August 14, 2025
Time: 8:30 a.m. Eastern time
U.S. Dial-In (Toll Free): 888-506-0062
International Dial-In: 973-528-0011
Participant Access Code: 939482
Webcast:
3Q Webcast Link
Please join at least five minutes before the start of the call to ensure timely participation.
A playback of the call will be available through Thursday, August 28, 2025. To listen, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 52598. A webcast replay will also be available using the webcast link above through August 28, 2025.
About NeuroOne
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit
www.nmtc1.com
.
IR Contact
MZ Group – MZ North America
[email protected]
